Trilaciclib dihydrochloride
Trilaciclib dihydrochloride is a CDK4/6 inhibitor used to reduce chemotherapy-induced myelosuppression.
| Catalog Number | API0233068 |
| Alternative Name(s) | 1977495-97-8; Trilaciclib dihydrochloride; G1T28 dihydrochloride |
| Research Area | API |
| Molecular Formula | C24H32Cl2N8O |
| CAS# | 1977495-97-8 |
| Inchi | InChI=1S/C24H30N8O.2ClH/c1-30-9-11-31(12-10-30)18-5-6-20(25-15-18)28-23-26-14-17-13-19-22(33)27-16-24(7-3-2-4-8-24)32(19)21(17)29-23;;/h5-6,13-15H,2-4,7-12,16H2,1H3,(H,27,33)(H,25,26,28,29);2*1H |
| Inchi Key | BRCYOXKEDFAUSA-UHFFFAOYSA-N |
| SMILES | CN1CCN(CC1)C2=CN=C(C=C2)NC3=NC=C4C=C5C(=O)NCC6(N5C4=N3)CCCCC6.Cl.Cl |
| Size | inquiry |
| Supplier Page | https://apihub.protheragen.ai/trilaciclib-dihydrochloride-item-1568.html |